FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
|
12-09-2016, 02:25 PM | #1 | |||
|
||||
Grand Magnate
|
Outcomes data showed ALS patients who discontinued treatment with MediciNova's ibudilast showed declines in muscle strength
Outcomes data showed ALS patients who discontinued treatment with MediciNova's ibudilast showed declines in muscle strength - MediciNova, Inc. (NASDAQ:MNOV) | Seeking Alpha |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
AB Science Reports Positive Interim Results in Phase 3 Trial of Masitinib as an ALS | ALS News & Research |